IRadimed Corporation
IRMD · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $57 | $53 | $50 | $52 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $14 | $11 | $13 | $11 |
| Inventory | $12 | $11 | $11 | $10 |
| Other Curr. Assets | $1 | $2 | $2 | $2 |
| Total Curr. Assets | $85 | $77 | $75 | $75 |
| Property Plant & Equip (Net) | $24 | $23 | $20 | $17 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $3 | $3 | $3 | $3 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $2 | $3 | $3 | $3 |
| Other NC Assets | $0 | $0 | $0 | $0 |
| Total NC Assets | $30 | $29 | $27 | $23 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $115 | $106 | $102 | $98 |
| Liabilities | – | – | – | – |
| Payables | $2 | $2 | $3 | $2 |
| Short-Term Debt | $0 | $0 | $0 | $0 |
| Tax Payable | $3 | $0 | $1 | $0 |
| Deferred Revenue | $3 | $3 | $3 | $2 |
| Other Curr. Liab. | $0 | $0 | $0 | $0 |
| Total Curr. Liab. | $13 | $9 | $8 | $9 |
| LT Debt | $0 | $0 | $0 | $0 |
| Deferred Rev, NC | $4 | $3 | $3 | $3 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $0 | $0 |
| Total NC Liab. | $4 | $3 | $3 | $3 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $0 | $0 | $0 |
| Total Liabilities | $16 | $12 | $12 | $12 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | $66 | $63 | $59 | $57 |
| AOCI | $0 | $0 | $0 | $0 |
| Other Equity | $0 | $0 | $0 | $0 |
| Total Equity | $98 | $94 | $90 | $87 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $115 | $106 | $102 | $98 |
| Net Debt | -$57 | -$53 | -$50 | -$52 |